bullish
Innovent Biologics (信达生物) Placement - Selling upon Lock-Up Expiry
891 Views16 Apr 2019 18:36
Undisclosed shareholders of Innovent Biologics Inc (1801 HK) is looking to sell part of its stake (36.2m shares, about US$125m) in the company. The...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Zhen Zhou, Toh
APAC IPOs & Placements
Price Chart(Sign Up to Access)
- Luckin Coffee (瑞幸咖啡) - Blue-Sky/Bear-Case Valuation03 May 2019
- ECM Weekly (27 April 2019) - Luckin, Duiba, Leong Hup, ARA US Hosp, Douyu, So-Young, Yunji27 Apr 2019
- ECM Weekly (18 April 2019) - Duiba Group, MabPharm, Huami, Cofco Meat, Innovent, Times China18 Apr 2019
- Keytruda Approved for Lung Cancer Treatment in China - A Review of PD-1 Battle Field11 Apr 2019
- Innovent Biologics (信达生物) Post IPO: Hit Our TP, What's Next?01 Nov 2018
- Innovent Biologics (信达生物) IPO: Limited Upside Despite Strong Cornerstones (Part 3)16 Oct 2018
x